Press release
Latest Report on COVID-19 Market Report- In-Depth Understanding of Epidemiology Data for Coronavirus Disease Market
ReportsnReports added a latest report on The COVID-19 Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Coronavirus Disease Market research report provides granular analysis of the market share, segmentation, revenue forecasts, geographic regions of the market and analytical tools such as SWOT analysis to generate a whole set of trade based studies regarding the COVID-19 Market.Get FREE PDF Sample of the report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3113867
The global CFR is 4.3%. In the 5MM, the highest case fatality rate occurs among the 80 years and older age group. In the 5MM (except Spain), the highest proportion of deaths occurs among the 80 years and older age group.
First reported in Wuhan, China, in December 2019, now more than 846,200 confirmed cases of COVID-19 are spread across 180 countries worldwide. China had appeared to gain control of COVID-19. The US is now the most heavily affected country worldwide.
Forecasts expect further rise in cases from the US and other countries across Europe. Italy and Switzerland may begin to see flattening of the epidemiological curve.
People at risk for severe COVID-19 include population with underlying health problems, such as respiratory disease, cardiovascular disease, cancer, diabetes, and some rare diseases.
Populations aged 50 years of age and older are also more likely to have comorbidities and develop severe COVID-19, requiring hospitalization.
There is no solid evidence to suggest that pregnant women are more at risk of COVID-19, but they are included in this category as a precaution. The epidemiology analysis is limited by several data restrictions. Testing availability and criteria differ significantly among countries.
All countries reported confirmed cases underestimate the number of actual infected people. And mortality reporting is not standardized.
Scope of this Report--
- The epidemiology report covers four areas: current epidemiology situation and forecast, populations at risk, case fatality rate, and data limitations.
- The forecast include three-scenario analysis of global confirmed case count, in-depth analysis of top four markets with confirmed cases, and a peak-week and return-to-normal week analysis for the top four markets.
- The populations at risk area focuses on 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and South Korea) and provides size of the populations that have COPD, heart disease, diabetes, and select rare diseases.
- The case fatality rate area provides comparison in case fatality and proprotion of deaths by age in four major markets (China, South Korea, US, and Italy). Data limitations provide readers with in-depth understanding of the caveats surronding the COVID-19 data.
Reasons to Access this Report-
- Obtain in-depth understanding of epidemiology data for COVID-19.
Purchase this Full Report and Get 20% Flat Discount @ https://www.reportsnreports.com/purchase.aspx?name=3113867
Table of Contents in Coronavirus Disease Market Report-
Executive Summary
Contents
1 Current Epidemiology Situation
1.1 Current Epidemiology Situation
1.2 Top 10 Infected Countries
2 Forecast for Key Markets
2.1 Forecast for Key Markets Global
2.2 Forecast for Key Markets 4MM
2.3 Forecast for Key Markets Peak Week
3 High-Risk Populations in Nine Major Markets
3.1 High-Risk Group Analysis: COPD
3.2 High-Risk Group Analysis: Diabetes, Heart Disease, and Rare Diseases
4 Case Fatality Rate Comparison
4.1 Case Fatality Rate Comparison
4.2 Proportion of Deaths by Age Group
5 What the Data Don?t Tell Us
5.1 Drawbacks to Available Data
6 Appendix
6.1 Methodology
6.2 Abbreviations
6.3 Related Reports
6.4 Sources
6.5 About the Authors
List of Tables in Coronavirus Disease Market Report-
Table 1. Current Epidemiology Situation
Table 2. Top 10 Infected Countries
Table 3. Confirmed Cases of COVID-19 4MM
Table 4. GlobalData COVID-19 Confirmed Cases Epidemiology Forecast for 6 April 2020
Table 5. Estimated Peak Week and Return to Normal Week
Table 6. Weekly Overview of COVID-19 Epidemiological Trends
List of Figures in Coronavirus Disease Market Report-
Figure 1. Global Confirmed Cases of COVID-19
Figure 2. Global New Cases of COVID-19
Figure 3. COVID-19 in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Nine Major Markets (9MM)
Figure 4. COVID-19 in Patients with Diabetes in Nine Major Pharmaceutical Markets
Figure 5. COVID-19 in Patients with Heart Disease in Nine Major Pharmaceutical Markets
Figure 6. COVID-19 in Patients with Rare Diseases in Nine Major Pharmaceutical Markets
Figure 7. Case Fatality Rates by Age Group
Figure 8. Proportion of Deaths by Age Group
and more...
Contact is us-
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Latest Report on COVID-19 Market Report- In-Depth Understanding of Epidemiology Data for Coronavirus Disease Market here
News-ID: 2007131 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…